What is the recommended medication regimen after placement of a drug‑eluting left circumflex coronary artery stent?

Medication Regimen After Left Circumflex Drug-Eluting Stent

After placement of a drug-eluting stent in the left circumflex artery, you must prescribe dual antiplatelet therapy (DAPT) consisting of aspirin 81 mg daily indefinitely plus a P2Y12 inhibitor (clopidogrel 75 mg, prasugrel 10 mg, or ticagrelor 90 mg twice daily) for at least 12 months. 1

Core Antiplatelet Regimen

Aspirin

• Loading dose: 162-325 mg before PCI if not already on aspirin 1, 2
• Maintenance dose: 81 mg daily indefinitely (preferred over higher doses) 1
• Continue aspirin for life after stent placement 1

P2Y12 Inhibitor Selection

For non-ACS (stable coronary disease):

• Clopidogrel 75 mg daily for at least 12 months if not at high bleeding risk 1
• Loading dose: 600 mg at time of PCI 1

For ACS (acute coronary syndrome): Choose one of three options for at least 12 months 1, 2, 3:

• Clopidogrel 75 mg daily (600 mg loading dose)
• Prasugrel 10 mg daily (60 mg loading dose) - more potent but higher bleeding risk
• Ticagrelor 90 mg twice daily (180 mg loading dose) - more potent but higher bleeding risk

Duration Considerations

Standard duration: 12 months of DAPT for drug-eluting stents 1

Shorter duration (3-6 months) may be reasonable if:

• High bleeding risk outweighs ischemic benefit 1
• Patient develops significant bleeding on DAPT 4, 5

Extended duration (>12 months) may be considered if:

• Patient tolerates DAPT well without bleeding 1, 6
• High ischemic risk (complex lesions, prior stent thrombosis, diabetes, multivessel disease) 5
• However, note increased bleeding risk and possible mortality signal with extended therapy 6

Critical Pitfalls to Avoid

1. Never discontinue DAPT prematurely without cardiology consultation - this dramatically increases stent thrombosis risk, which can be fatal 1

2. Counsel patients extensively before stent placement about:

   • Absolute necessity of medication compliance
   • Financial ability to afford medications for full duration
   • Upcoming surgeries that might require DAPT interruption 1

3. Avoid elective surgery within 12 months of stent placement when possible 7

4. If surgery is unavoidable: Continue aspirin perioperatively if at all possible; only stop P2Y12 inhibitor 5-7 days before surgery and restart immediately after 7

Additional Medications

Gastroprotection

• Proton pump inhibitor should be used if history of GI bleeding 1
• Reasonable to use if high GI bleeding risk (age >65, concurrent warfarin, NSAIDs, H. pylori) 1
• Not routinely needed in low-risk patients 1

Cardiovascular Risk Reduction

Beyond antiplatelet therapy, ensure:

• Statin therapy (high-intensity preferred) 8, 9
• ACE inhibitor or ARB if hypertension, diabetes, LV dysfunction, or chronic kidney disease 8, 9
• Beta-blocker if prior MI or LV dysfunction 8, 9
• Blood pressure control, diabetes management, smoking cessation 8, 9

Special Situations

If patient requires anticoagulation (atrial fibrillation, mechanical valve):

• Use DOAC (preferred over warfarin) plus clopidogrel 75 mg 5, 10
• Stop aspirin after ≤1 week post-PCI 5
• Continue dual therapy (DOAC + clopidogrel) for 6-12 months depending on ischemic risk 5
• Then transition to anticoagulation alone 5
• Triple therapy (aspirin + P2Y12 + anticoagulation) dramatically increases bleeding and should be minimized 9, 5, 10

High bleeding risk patients:

• Consider bare metal stent instead if appropriate 2
• If DES placed, minimum 1-3 months DAPT may be acceptable 4, 5
• Transition to P2Y12 monotherapy (stopping aspirin) after 1-3 months is emerging strategy 4, 5